Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher P. Prior currently holds 7,009 shares of INNOVATE BIOPHARMACEUTICALS, INC. (INNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher P. Prior has been a net buyer of INNT stock. They have purchased $24.5K and sold $0 worth of shares.
Christopher P. Prior's most recent insider trade was on Nov 29, 2018, when they purchased 5,000 shares at $2.75 per share.
Christopher P. Prior serves as Executive at INNOVATE BIOPHARMACEUTICALS, INC. (INNT). They have executed 5 insider transactions totaling $24.5K over their tenure at the company.
Christopher P. Prior holds the position of Executive at INNOVATE BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Christopher P. Prior has shown a buying trading pattern, with $24.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher P. Prior was on Nov 29, 2018, when they purchased $13.8K worth of INNT shares. This transaction involved 5,000 shares at $2.75 per share.
Christopher P. Prior currently owns 7,009 shares of INNOVATE BIOPHARMACEUTICALS, INC. (INNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher P. Prior's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher P. Prior has 5 Form 4 filings on record as an insider at INNOVATE BIOPHARMACEUTICALS, INC..
Set alerts for Christopher P. Prior and 40,000+ other insiders.